60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treat...
- Open
- 1.140
- High
- 1.160
- Low
- 1.100
- Prev. Close
- 1.120
- Volume
- 30.53K
- Turnover
- 34.30K
- Avg Price
- 1.123
- Bid/Ask Ratio
- -58.27%
- Amplitude
- 5.36%
- 52wk High
- 8.620
- Volume Ratio
- 1.24
- Turnover Ratio
- 1.17%
60 Degrees Pharmaceuticals Analyst Rating
View moreForecast & Rating
Aug 17, 2026Price forecast
$3.70218.97%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Aug 14 at 02:41 PM
60 DEGREES PHARMACEUTICALS, INC. 2026: Revenue $207.9K, EPS ($0.9) — 10-Q Summary
- Quartr · Aug 14 at 02:36 PM
SXTP: Q2 revenue doubled year-over-year, but losses and cash burn raise going concern risks
- PUBT · Aug 14 at 02:35 PM
60 Degrees Pharma Q2 FY26 net loss widens 30.6% to $2.26 million; revenue more than doubles to $207,898
- StockTitan · Aug 14 at 06:47 AM
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results | SXTP Stock News
- PUBT · Aug 6 at 03:50 PM
60 Degrees Pharmaceuticals holds annual shareholder meeting
- PUBT · Aug 4 at 04:39 PM
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement
